140 results
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
contribute to the Claim for which such indemnity is held unavailable in such proportion as is appropriate to reflect the relative benefits … .’ engagement. The Company hereby agrees that the relative benefits to the Company, on the one hand, and A.G.P. on the other, with respect to A.G.P.’ engagement
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include
8-K
EX-10.1
pu02 2luj5mz
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
424B5
vmn1kop86dp
2 Oct 23
Prospectus supplement for primary offering
4:52pm
8-K
EX-1.1
kcf2vm6m0
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
424B5
tcfpw7 x087p
21 Jul 23
Prospectus supplement for primary offering
4:39pm
8-K
EX-10.1
o8scx5l1 3s0
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm